Moores Surgical Oncologists as Scientists (SOAS) Training Program
|
Dr. Jason Sicklick (SFG) and Dr. Yuan Chen (CBS) were awarded an NCI T32, Surgical Oncologists as Scientists (SOAS) Training Program, which will receive $1.5M over 5 years. The goal of SOAS is to provide research training for surgical residents committed to a career in academic surgical oncology. SOAS comprises three main training areas: (1) laboratory-based translational career research; (2) biospecimen banking in our College of American Pathologists (CAP)-certified biorepository; (3) innovation and entrepreneurship. SOAS will enable trainees to become future leaders in academic surgery and oncology. SOAS is a joint collaboration between the Department of Surgery and Moores Cancer Center, which will fund four MD/DO surgeon-scientist trainees for a 2-year training program. Read More»
|
NIH Funding Programs by Career Stage
|
The NIH has just released a new graphic, complete with clickable links, to summarize its set of funding mechanisms, with respect to career stage. Moores members may find this graphic useful for planning a new research project, developing a training program, or mentoring a graduate or postdoctoral trainee. View Graphic»
|
|
|
July 20, 2023 | 12:00 p.m. PT
|
July 24–27, 2023
Salk Institute for Biological Studies
|
July 25, 2023 | 3:00 p.m. ET
Zoom
|
August 1–4, 2023
Salk Institute for Biological Studies
|
|
|
NCI Cancer Prevention Fellowship Program
|
Applications for this postdoctoral fellowship program are open through August 1, 2023.
|
|
Applications for KL2 Mentored Career Development Award Now Open!
|
The ACTRI KL2 award is a mentored career development award that provides up to $120K toward salary, plus benefits, along with $25K per year in research funds. Successful applicants will receive up to 3 years of support. Applications for this program are open through August 15, 2023.
|
|
|
FEATURED FUNDING OPPORTUNITIES |
This retention-focused, institutionally-supported program will support under-represented minority faculty members in submitting successful resubmissions of NIH K or R (or equivalent) grant applications. The goal of the SUSTAIN program is to increase the likelihood of successful proposal resubmission by providing protected time, grant writing training, and linkage to didactic, mentorship, and other resources, which are customized to the applicant. The SUSTAIN program provides 1–2 years of support at 50% of full-time salary (up to $60,000), which must be matched by the department and confirmed in a letter from the candidate’s Department Chair. The combined effort must enable a total of at least 75% research effort.
Deadline: Friday, September 1, 2023
|
The Minnesota Ovarian Cancer Alliance will award up to $150,000 in November 2023 to support research on the early detection of ovarian cancer.
Deadline: Friday, September 1, 2023
|
The BCRP Clinical Research Extension Award aims to (1) extend or expand the data collection, follow-up, and analysis of breast cancer clinical studies and (2) increase the clinically relevant impact of breast cancer patient participation in clinical research by addressing the knowledge lost due to early trial termination, limited patient follow-up, or suboptimal sample and/or data collection and analysis. Patient contributions of tissue, serum, and other biologic specimens and their data are invaluable to saving lives. This BCRP mechanism helps to ensure that science values those contributions with research that maximizes their impact.
Deadline: Tuesday, September 12, 2023
|
This Notice of Funding Opportunity (NOFO) invites proposals for research centers to advance cancer control equity by stimulating community-engaged, multilevel research interventions that address the impact of social determinants of health (SDOH) on adverse cancer control outcomes. Each Research Center will (1) develop interventions that target the multilevel pathways by which SDOH impact adverse cancer outcomes, (2) develop measures, methods, and assess community-level SDOH, community engagement and cancer control equity processes and outcomes, and (3) build capacity and engagement among scholars from diverse backgrounds, which include those from groups underrepresented in the biomedical sciences, and community partners to implement interventions that incorporate the lived experiences of those who face cancer inequities.
Deadline: Thursday, September 14, 2023
|
|
|
Fructose-1,6-bisphosphatase is a nonenzymatic safety valve that curtails AKT activation to prevent insulin hyperresponsiveness
|
Cell Metabolism
Alexandra C. Newton (Cancer Biology and Signaling), Tatiana Kisseleva (Cancer Biology and Signaling), and Michael Karin (Solid Tumor Therapeutics)
|
The GPCR-Gαs-PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure
|
Nature Immunology
Hannah Carter (Structrual and Functional Genomics), Jill P. Mesirov (Structrual and Functional Genomics), and J. Silvio Gutkind (Cancer Biology and Signaling)
|
Method for estimation of apoptotic cell fraction of cytotherapy using in vivo fluorine-19 magnetic resonance: Pilot study in a patient with head and neck carcinoma receiving tumor-infiltrating lymphocytes labeled with perfluorocarbon nanoemulsion
|
Journal of Immunotherapy of Cancer
Eric T. Ahrens (Solid Tumor Therapeutics), Karen Messer (Cancer Control Program), and Gregory A. Daniels (Solid Tumor Therapeutics)
|
|
|
ICP-CL-00303: A Multicenter Open-label, Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ICP192 in Patients with Advanced Solid Tumors and FGFR Gene Alterations
|
PI: Shumei Kato
NCT: NCT04565275
|
|
|
COMMUNITY OUTREACH AND ENGAGEMENT |
COE at the Jackie Robinson Family YMCA
|
The Moores COE team collaborated with its community partners at the Jackie Robinson Family YMCA Community Health and Resource Fair in Southeast San Diego this past Wednesday, July 5. About 105 community members visited the Moores COE table to receive resources on cancer prevention, sunscreen, and snacks. The team answered questions about cancer risk factors, where to find screening tests, and the differences between cancer screenings tests offered by providers. Join Moores COE at the next monthly Community Health & Resource Fair, which is held the first Wednesday of every month from 10:00 a.m. to 3:00 p.m. at the Jackie Robinson Family YMCA, on August 2, 2023. This event provides essentiall preventative health services, fresh food and vegetables, and supportive resources for some of our most underserved neighbors in San Diego.
|
UCSD Health Equity Consortium Seminar
|
Please join the Moores Center for Health Equity and Education Research (CHEER) and COE on Friday, July 14 for the UCSD Health Equity Consortium Seminar. Dr. Marc Emerson will deliver a presentation titled, "Addressing Cancer Care Inequities in Black and American Indian / Alaskan Native Populations." Dr. Emerson is an Assistant Professor of Epidemiology at UNC Chapel Hill and is Diné (Navajo) and Jemez from the Navajo Nation. The seminar will take place in the Moores Comer Commons. This seminar is free, in-person, and intended for academic researchers, clinicians, cancer center staff, and native-focused organizations/groups. Please contact Elizabeth Duran at e2duran@health.ucsd.edu for information.
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
3855 Health Sciences Drive MC 0698 | La Jolla, CA 92093 US
|
|
|
This email was sent to sjchristie@health.ucsd.edu.
To continue receiving our emails, add us to your address book.
|
|
|
|
